Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,999,698
+$7,273,524 QoQ
Shares Held
501,614
+65.1% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 198 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Derivatives in NAMS
reported options exposure · as of Jun 30, 2026CallValue
$1,602,750
CallShares
75,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. NAMS ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in NAMS
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 NAMSW | $1,602,750 | 75,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $16,999,698 | 501,614 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 NAMSW | $1,503,000 | 75,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $9,726,174 | 303,848 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 NAMSW | $1,725,000 | 75,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $8,931,227 | 254,596 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 NAMSW | $1,283,250 | 75,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 NAMSW | $600,000 | 75,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $495,217 | 27,345 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 NAMSW | $674,250 | 75,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $292,721 | 14,300 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 NAMSW | $1,068,750 | 75,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $12,701,711 | 494,230 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 NAMSW | $525,000 | 75,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $278,033 | 16,749 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 NAMSW | $654,000 | 75,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $22,387,891 | 1,165,429 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 NAMSW | $828,000 | 75,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $22,409,013 | 947,527 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 NAMSW | $234,750 | 75,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $14,812,570 | 1,326,103 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 NAMSW | $142,500 | 75,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $9,664,252 | 1,044,784 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 NAMSW | $156,750 | 75,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $4,441,533 | 373,552 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 NAMSW | $138,000 | 75,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $737,693 | 55,633 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 NAMSW | $65,100 | 75,000 | Call | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||